Biochemical Parameters in Renal Failure

-BIOCHEMISTRY-
PREMIUM THESIS TOPICS

Since Its Almost Impossible or at least very difficult to change the thesis topics once its approved by institutional ethical committee. Its therefor important that you choose a good as well as easy to do thesis. There is no point in unnecessarily choosing a complex thesis topic and getting frustrated for the rest of your residency.                                                                       You can discuss with me before choosing any thesis topic and i will advice you accordingly. 

Biochemical Parameters in Renal Failure

List of  premium Biochemistry thesis topics to choose from. You can take our advice before selecting any thesis topics as once approved by ethical committee its difficult to change thesis topics later. 

This page covers renal dysfunction thesis topics across renal function markers, electrolytes and acid–base balance, mineral metabolism, cardiovascular and metabolic biochemistry, inflammation and oxidative stress, and vitamin, micronutrient and anaemia-related parameters in chronic kidney disease. The topics are intended for MD Biochemistry candidates and can generally be completed within one thesis period using routinely available patients, clinical records and laboratory investigations. The list also supports candidates searching for renal biochemistry research topics, while a structured biochemistry protocol or biochemistry synopsis can be developed once the final renal endpoint, CKD definition and laboratory methods are fixed.

Last reviewed and updated: August 2026

📌 Updated for 2026–2027 MD Biochemistry admissions

The list was reviewed for CKD staging, renal biomarker interpretation, assay-related limitations and practical laboratory feasibility.

  • Most topics can be completed with serum creatinine, urea, electrolytes, bicarbonate, calcium, phosphorus, albumin, lipid profile, iron studies, vitamin D and selected inflammatory or endocrine assays.
  • Measured GFR, renal biopsy, advanced proteomics and specialised molecular assays are not required for the majority of these projects.
  • Publication potential is strongest where CKD stage, eGFR equation, creatinine assay, dialysis status and major confounders are prespecified before analysis.
Generate a protocol from any topic below

Select Generate Protocol → beside any title and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already know your thesis title?

Skip the list and generate the full renal function parameters and biochemical markers of renal dysfunction protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Renal Function Parameters and Biochemical Markers of Renal Dysfunction

  1. A cross-sectional study of serum urea, creatinine, and estimated glomerular filtration rate and their interrelationship in patients with chronic kidney disease.
  2. A comparative cross-sectional study of serum urea and creatinine levels across different stages of chronic kidney disease.
  3. An observational study of the association between serum creatinine and estimated glomerular filtration rate in patients with chronic kidney disease.
  4. A cross-sectional study of serum cystatin C and its association with serum creatinine and estimated glomerular filtration rate in patients with chronic kidney disease.
  5. A comparative study of serum cystatin C levels in patients with chronic kidney disease and apparently healthy individuals.
  6. A comparative cross-sectional study of serum cystatin C and serum creatinine as biochemical markers of renal dysfunction in patients with chronic kidney disease.
  7. A cross-sectional study of serum cystatin C levels across different stages of chronic kidney disease.
  8. An observational study of the association between serum cystatin C and conventional renal function parameters in patients with chronic kidney disease.
  9. A cross-sectional study of serum uric acid and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
  10. A comparative cross-sectional study of serum uric acid levels across different stages of chronic kidney disease.
  11. A cross-sectional study of serum uric acid and its association with serum urea and creatinine in patients with chronic kidney disease.
  12. A comparative study of serum uric acid levels in patients with chronic kidney disease and apparently healthy individuals.
  13. An observational study of the association between hyperuricemia and severity of renal dysfunction in patients with chronic kidney disease.
  14. A cross-sectional study of urinary albumin-to-creatinine ratio and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
  15. A comparative cross-sectional study of biochemical renal function parameters in patients with chronic kidney disease with and without albuminuria.
  16. A cross-sectional study of urinary protein-to-creatinine ratio and its association with renal function parameters in patients with chronic kidney disease.
  17. A comparative study of urinary albumin-to-creatinine ratio and urinary protein-to-creatinine ratio in the biochemical assessment of patients with chronic kidney disease.
  18. An observational study of the association between proteinuria and serum creatinine in patients with chronic kidney disease.
  19. A cross-sectional study of serum albumin and its association with urinary protein excretion in patients with chronic kidney disease.
  20. A comparative cross-sectional study of serum albumin levels across different stages of chronic kidney disease.
  21. A cross-sectional study of serum total protein, albumin, and globulin levels in patients with chronic kidney disease.
  22. A comparative study of serum total protein and albumin levels in patients with chronic kidney disease and apparently healthy individuals.
  23. An observational study of the association between serum albumin and estimated glomerular filtration rate in patients with chronic kidney disease.
  24. A cross-sectional study of blood urea nitrogen to creatinine ratio and its association with severity of renal dysfunction in patients with chronic kidney disease.
  25. A comparative cross-sectional study of blood urea nitrogen to creatinine ratio across different stages of chronic kidney disease.
  26. A cross-sectional study of serum creatinine-to-cystatin C ratio and its association with renal function in patients with chronic kidney disease.
  27. A comparative study of creatinine-based and cystatin C-based estimates of glomerular filtration rate in patients with chronic kidney disease.
  28. A cross-sectional study of conventional and novel renal function markers and their association with chronic kidney disease severity.
  29. A comparative cross-sectional study of renal function parameters in patients with diabetic and non-diabetic chronic kidney disease.
  30. An observational study of the association of age and sex with biochemical renal function parameters in patients with chronic kidney disease.

Electrolytes, Acid-Base Balance and Mineral Metabolism

  1. A cross-sectional study of serum sodium and potassium levels and their association with severity of chronic kidney disease.
  2. A comparative cross-sectional study of serum sodium levels across different stages of chronic kidney disease.
  3. A comparative study of serum potassium levels across different stages of chronic kidney disease.
  4. An observational study of the association between serum potassium and estimated glomerular filtration rate in patients with chronic kidney disease.
  5. A cross-sectional study of serum sodium, potassium, and chloride levels in patients with chronic kidney disease.
  6. A comparative study of serum electrolyte levels in patients with chronic kidney disease and apparently healthy individuals.
  7. A cross-sectional study of serum bicarbonate levels and their association with estimated glomerular filtration rate in patients with chronic kidney disease.
  8. A comparative cross-sectional study of serum bicarbonate levels across different stages of chronic kidney disease.
  9. An observational study of the association between metabolic acidosis and renal function parameters in patients with chronic kidney disease.
  10. A cross-sectional study of serum bicarbonate and potassium levels and their association with severity of renal dysfunction in patients with chronic kidney disease.
  11. A cross-sectional study of serum total calcium and phosphorus levels and their association with severity of chronic kidney disease.
  12. A comparative cross-sectional study of serum calcium levels across different stages of chronic kidney disease.
  13. A comparative study of serum phosphorus levels across different stages of chronic kidney disease.
  14. An observational study of the association between serum phosphorus and estimated glomerular filtration rate in patients with chronic kidney disease.
  15. A cross-sectional study of calcium-phosphorus product and its association with severity of chronic kidney disease.
  16. A comparative study of calcium-phosphorus product in patients with chronic kidney disease and apparently healthy individuals.
  17. A cross-sectional study of serum magnesium levels and their association with estimated glomerular filtration rate in patients with chronic kidney disease.
  18. A comparative cross-sectional study of serum magnesium levels across different stages of chronic kidney disease.
  19. A comparative study of serum magnesium levels in patients with chronic kidney disease and apparently healthy individuals.
  20. An observational study of the association between serum magnesium and calcium-phosphorus product in patients with chronic kidney disease.
  21. A cross-sectional study of serum intact parathyroid hormone levels and their association with chronic kidney disease severity.
  22. A comparative cross-sectional study of serum parathyroid hormone levels across different stages of chronic kidney disease.
  23. A cross-sectional study of serum parathyroid hormone and its association with calcium and phosphorus levels in patients with chronic kidney disease.
  24. An observational study of the association between serum parathyroid hormone and estimated glomerular filtration rate in patients with chronic kidney disease.
  25. A comparative study of serum parathyroid hormone levels in patients with chronic kidney disease with and without hyperphosphatemia.
  26. A cross-sectional study of serum alkaline phosphatase and its association with calcium, phosphorus, and parathyroid hormone in patients with chronic kidney disease.
  27. A comparative cross-sectional study of serum alkaline phosphatase levels across different stages of chronic kidney disease.
  28. A cross-sectional study of biochemical markers of mineral and bone metabolism in patients with chronic kidney disease.
  29. A comparative study of calcium, phosphorus, alkaline phosphatase, and parathyroid hormone in patients with chronic kidney disease and apparently healthy individuals.
  30. A cross-sectional study of electrolyte, acid-base, and mineral abnormalities and their association with severity of chronic kidney disease.

Lipid, Cardiovascular and Metabolic Biochemical Parameters

  1. A cross-sectional study of serum lipid profile and its association with severity of chronic kidney disease.
  2. A comparative cross-sectional study of serum lipid profile across different stages of chronic kidney disease.
  3. A comparative study of serum lipid profile in patients with chronic kidney disease and apparently healthy individuals.
  4. An observational study of the association between serum triglycerides and estimated glomerular filtration rate in patients with chronic kidney disease.
  5. A cross-sectional study of high-density lipoprotein cholesterol and its association with renal function parameters in patients with chronic kidney disease.
  6. A comparative cross-sectional study of lipid abnormalities in diabetic and non-diabetic patients with chronic kidney disease.
  7. A cross-sectional study of total cholesterol to high-density lipoprotein cholesterol ratio and its association with severity of chronic kidney disease.
  8. A comparative study of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio across different stages of chronic kidney disease.
  9. A cross-sectional study of triglyceride to high-density lipoprotein cholesterol ratio and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
  10. An observational study of the association between lipid ratios and proteinuria in patients with chronic kidney disease.
  11. A cross-sectional study of atherogenic index of plasma and its association with severity of chronic kidney disease.
  12. A comparative study of atherogenic index of plasma in patients with chronic kidney disease and apparently healthy individuals.
  13. A comparative cross-sectional study of atherogenic index of plasma in diabetic and non-diabetic patients with chronic kidney disease.
  14. A cross-sectional study of non-high-density lipoprotein cholesterol and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
  15. A comparative study of non-high-density lipoprotein cholesterol across different stages of chronic kidney disease.
  16. A cross-sectional study of calculated remnant cholesterol and its association with renal function parameters in patients with chronic kidney disease.
  17. A comparative cross-sectional study of calculated remnant cholesterol in patients with chronic kidney disease and apparently healthy individuals.
  18. An observational study of the association between atherogenic lipid indices and serum uric acid in patients with chronic kidney disease.
  19. A cross-sectional study of serum apolipoprotein A1 and apolipoprotein B and their association with renal function in patients with chronic kidney disease.
  20. A comparative study of apolipoprotein B to apolipoprotein A1 ratio in patients with chronic kidney disease and apparently healthy individuals.
  21. A cross-sectional study of serum lipoprotein(a) and its association with severity of chronic kidney disease.
  22. A comparative cross-sectional study of serum lipoprotein(a) levels across different stages of chronic kidney disease.
  23. A cross-sectional study of fasting plasma glucose and glycated hemoglobin and their association with renal function in diabetic chronic kidney disease.
  24. A comparative study of glycemic parameters in patients with diabetic chronic kidney disease across different stages of renal dysfunction.
  25. An observational study of the association between glycated hemoglobin and estimated glomerular filtration rate in patients with diabetic chronic kidney disease.
  26. A cross-sectional study of triglyceride-glucose index and its association with renal function in patients with chronic kidney disease.
  27. A comparative study of triglyceride-glucose index in patients with chronic kidney disease and apparently healthy individuals.
  28. A cross-sectional study of serum uric acid, lipid profile, and atherogenic indices as biochemical cardiovascular risk markers in chronic kidney disease.
  29. A comparative cross-sectional study of conventional and calculated lipid risk indices in patients with chronic kidney disease.
  30. An observational study of the association between dyslipidemia, proteinuria, and renal dysfunction in patients with chronic kidney disease.

Inflammation, Oxidative Stress and Nutritional Biochemical Parameters

  1. A cross-sectional study of high-sensitivity C-reactive protein and its association with severity of chronic kidney disease.
  2. A comparative study of high-sensitivity C-reactive protein levels in patients with chronic kidney disease and apparently healthy individuals.
  3. A comparative cross-sectional study of high-sensitivity C-reactive protein levels across different stages of chronic kidney disease.
  4. An observational study of the association between high-sensitivity C-reactive protein and estimated glomerular filtration rate in patients with chronic kidney disease.
  5. A cross-sectional study of high-sensitivity C-reactive protein and serum albumin as biochemical markers of inflammation and nutritional status in chronic kidney disease.
  6. A comparative study of high-sensitivity C-reactive protein levels in diabetic and non-diabetic patients with chronic kidney disease.
  7. A cross-sectional study of C-reactive protein to albumin ratio and its association with severity of chronic kidney disease.
  8. A comparative cross-sectional study of C-reactive protein to albumin ratio across different stages of chronic kidney disease.
  9. An observational study of the association between C-reactive protein to albumin ratio and estimated glomerular filtration rate in patients with chronic kidney disease.
  10. A cross-sectional study of serum ferritin and its association with inflammatory markers in patients with chronic kidney disease.
  11. A comparative study of serum ferritin levels in patients with chronic kidney disease and apparently healthy individuals.
  12. A cross-sectional study of serum ferritin and its association with renal function parameters in patients with chronic kidney disease.
  13. A comparative cross-sectional study of serum ferritin levels across different stages of chronic kidney disease.
  14. An observational study of the association between serum ferritin and high-sensitivity C-reactive protein in patients with chronic kidney disease.
  15. A cross-sectional study of serum malondialdehyde as a marker of oxidative stress and its association with renal dysfunction in chronic kidney disease.
  16. A comparative study of serum malondialdehyde levels in patients with chronic kidney disease and apparently healthy individuals.
  17. A comparative cross-sectional study of serum malondialdehyde levels across different stages of chronic kidney disease.
  18. A cross-sectional study of total antioxidant capacity and its association with estimated glomerular filtration rate in patients with chronic kidney disease.
  19. A comparative study of total antioxidant capacity in patients with chronic kidney disease and apparently healthy individuals.
  20. An observational study of the association between oxidative stress and inflammatory markers in patients with chronic kidney disease.
  21. A cross-sectional study of serum uric acid and total antioxidant capacity in patients with chronic kidney disease.
  22. A comparative cross-sectional study of oxidative stress markers in diabetic and non-diabetic patients with chronic kidney disease.
  23. A cross-sectional study of serum albumin and its association with inflammatory and oxidative stress markers in patients with chronic kidney disease.
  24. A comparative study of serum albumin levels in patients with chronic kidney disease with and without systemic inflammation.
  25. A cross-sectional study of serum prealbumin and its association with biochemical markers of renal dysfunction in chronic kidney disease.
  26. A comparative cross-sectional study of serum prealbumin and albumin as biochemical indicators of nutritional status in chronic kidney disease.
  27. A cross-sectional study of serum total protein, albumin, cholesterol, and inflammatory markers as biochemical indicators of nutritional status in chronic kidney disease.
  28. An observational study of the association between serum albumin and lipid abnormalities in patients with chronic kidney disease.
  29. A comparative study of inflammatory and nutritional biochemical parameters in diabetic and non-diabetic chronic kidney disease.
  30. A cross-sectional study of inflammatory, oxidative stress, and nutritional biochemical markers and their association with severity of chronic kidney disease.

Vitamins, Micronutrients, Anaemia-Related and Endocrine Biochemical Parameters

  1. A cross-sectional study of serum vitamin D levels and their association with severity of chronic kidney disease.
  2. A comparative study of serum vitamin D levels in patients with chronic kidney disease and apparently healthy individuals.
  3. A comparative cross-sectional study of serum vitamin D levels across different stages of chronic kidney disease.
  4. An observational study of the association between serum vitamin D and estimated glomerular filtration rate in patients with chronic kidney disease.
  5. A cross-sectional study of serum vitamin D and parathyroid hormone levels and their association with mineral abnormalities in chronic kidney disease.
  6. A comparative study of serum vitamin D levels in patients with chronic kidney disease with and without secondary hyperparathyroidism.
  7. A cross-sectional study of serum vitamin D, calcium, phosphorus, and alkaline phosphatase as biochemical markers of mineral and bone abnormalities in chronic kidney disease.
  8. A comparative cross-sectional study of serum vitamin D and parathyroid hormone levels across different stages of chronic kidney disease.
  9. An observational study of the association between serum vitamin D and inflammatory markers in patients with chronic kidney disease.
  10. A cross-sectional study of serum vitamin D and albumin levels and their association with severity of chronic kidney disease.
  11. A cross-sectional study of serum iron, ferritin, total iron-binding capacity, and transferrin saturation in patients with chronic kidney disease.
  12. A comparative study of iron profile parameters in patients with chronic kidney disease and apparently healthy individuals.
  13. A comparative cross-sectional study of iron status across different stages of chronic kidney disease.
  14. A cross-sectional study of serum ferritin and transferrin saturation and their association with hemoglobin levels in patients with chronic kidney disease.
  15. An observational study of the association between iron profile parameters and renal dysfunction in patients with chronic kidney disease.
  16. A comparative study of biochemical iron status in patients with chronic kidney disease with and without anemia.
  17. A cross-sectional study of serum vitamin B12 and folate levels in patients with chronic kidney disease with anemia.
  18. A comparative cross-sectional study of serum vitamin B12 levels in patients with chronic kidney disease and apparently healthy individuals.
  19. A cross-sectional study of serum homocysteine and its association with renal function parameters in patients with chronic kidney disease.
  20. A comparative study of serum homocysteine levels across different stages of chronic kidney disease.
  21. A cross-sectional study of serum homocysteine and its association with vitamin B12 and folate levels in patients with chronic kidney disease.
  22. A comparative cross-sectional study of serum homocysteine levels in patients with chronic kidney disease and apparently healthy individuals.
  23. A cross-sectional study of serum zinc levels and their association with severity of chronic kidney disease.
  24. A comparative study of serum zinc levels in patients with chronic kidney disease and apparently healthy individuals.
  25. A cross-sectional study of serum copper and zinc levels and copper-to-zinc ratio in patients with chronic kidney disease.
  26. A comparative cross-sectional study of copper-to-zinc ratio across different stages of chronic kidney disease.
  27. A cross-sectional study of thyroid-stimulating hormone and thyroid hormone levels and their association with severity of chronic kidney disease.
  28. A comparative study of thyroid function parameters in patients with chronic kidney disease and apparently healthy individuals.
  29. An observational study of the association between thyroid-stimulating hormone and estimated glomerular filtration rate in patients with chronic kidney disease.
  30. A comparative cross-sectional study of vitamin D, parathyroid hormone, thyroid function, iron profile, and micronutrient parameters in patients with chronic kidney disease and apparently healthy individuals.

Alongside renal function parameters and biochemical markers of renal dysfunction protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Renal function parameters and biochemical markers of renal dysfunction research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the renal function parameters and biochemical markers of renal dysfunction research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the renal function parameters and biochemical markers of renal dysfunction research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a renal function parameters and biochemical markers of renal dysfunction research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — QCHP and Hamad Medical Corporation. A renal function parameters and biochemical markers of renal dysfunction IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning renal function parameters and biochemical markers of renal dysfunction research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the renal function parameters and biochemical markers of renal dysfunction research proposal is the document assessed at the start of it.

Kuwait — KIMS. A renal function parameters and biochemical markers of renal dysfunction study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the renal function parameters and biochemical markers of renal dysfunction proposal follows the same structure throughout.

Generate a renal function parameters and biochemical markers of renal dysfunction research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A renal function parameters and biochemical markers of renal dysfunction dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full renal function parameters and biochemical markers of renal dysfunction research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

These are written individually, by a medical doctor, with no artificial intelligence generation and no plagiarism, and revised until the supervisor accepts them.

Enquire about a renal function parameters and biochemical markers of renal dysfunction PhD or MMed proposal →

🔥 Trending research areas in renal biochemistry for 2026–27

  • Creatinine versus cystatin C based filtration estimates: increasingly relevant because muscle mass, age and nutritional status can distort creatinine-based eGFR.
  • CKD mineral and bone disorder: integrated analysis of calcium, phosphorus, alkaline phosphatase, vitamin D and parathyroid hormone provides clinically interpretable biochemical phenotypes.
  • Inflammation and malnutrition: albumin, hs-CRP, ferritin and derived ratios are being studied together because inflammation alters several conventional nutritional markers.
  • Cardiometabolic biochemical risk: atherogenic indices, uric acid, homocysteine and triglyceride-glucose derived measures are being examined as accessible correlates of cardiovascular risk in CKD.

Protocol and synopsis guidance

What a renal biochemistry protocol must contain

Fix the definition and stage of CKD before recruitment. A protocol should state the diagnostic criteria used, whether chronicity has been documented for at least three months, the eGFR equation applied, the creatinine units used and whether participants receiving dialysis are included or analysed separately. A single raised creatinine does not by itself establish chronic kidney disease.

Renal biomarkers are strongly method-dependent. Creatinine-based eGFR depends on the creatinine assay and equation, while cystatin C can be influenced by inflammation, corticosteroid exposure and thyroid status. The assay platform, calibration approach and equation should therefore be stated explicitly rather than treating all estimates of renal function as interchangeable.

Timing matters in dialysis and acute biochemical change. Electrolytes, bicarbonate, urea, creatinine, calcium and phosphorus can change markedly before and after haemodialysis. If dialysis patients are included, the protocol should define whether samples are pre-dialysis, post-dialysis or collected on a non-dialysis day and should use the same time anchor for all participants.

Renal biochemistry synopsis versus renal biochemistry protocol

A synopsis is the concise academic plan submitted for departmental or university approval, whereas the protocol is the operational document used to conduct the study. For renal biochemistry, the protocol should specify CKD criteria, staging system, eGFR equation, assay methods, dialysis status, sample timing and how potentially distorting conditions such as acute kidney injury, severe malnutrition or corticosteroid therapy will be handled.

The distinction is important because a title such as a comparison of creatinine and cystatin C can appear simple while producing misleading results if the reference equation, assay standardisation or patient phenotype is not defined. The synopsis may describe the broad comparison, but the protocol must lock down these methodological details before data collection.

Sample size and statistical analysis

Base the calculation on the primary renal outcome. Comparisons across CKD stages usually require an expected difference in means or proportions, correlation studies require an anticipated correlation coefficient, and diagnostic-marker studies need assumptions for sensitivity, specificity or agreement. The calculation should follow the intended primary analysis rather than the number of biomarkers being measured.

Do not treat CKD stage as a simple numerical scale without justification. Stage is ordinal, while eGFR is continuous. Analyses should preserve the underlying continuous information when appropriate and use stage categories for clinically meaningful comparisons. If several stages are compared, the statistical plan should account for multiple groups and ordered trends.

Expect non-normal distributions and confounding. Parathyroid hormone, ferritin, hs-CRP, triglycerides and proteinuria measures are often skewed. Transformation or non-parametric testing may be required. Multivariable analysis should consider age, sex, diabetes, hypertension, nutritional status, dialysis exposure, medications and inflammation because these factors can affect both renal function and the biochemical marker being studied.

Frequently Asked Questions – Renal Function Parameters And Biochemical Markers Of Renal Dysfunction (2026–27)

1. How do I choose a feasible renal biochemistry thesis topic in 2026?

Choose a question that matches the CKD population available in the centre and the assays that can be performed consistently. Studies using creatinine, eGFR, albuminuria, electrolytes, bicarbonate, mineral markers, lipid profile or iron parameters are usually more feasible than projects dependent on expensive novel biomarkers. The strongest topic has one primary renal-biochemical question, a clearly defined CKD population and a prespecified method for staging or measuring renal dysfunction.

2. Which study designs are accepted for renal biochemistry research?

Cross-sectional, comparative cross-sectional, case-control, cohort and retrospective record-based designs are all suitable when aligned with the objective. Cross-sectional studies are useful for biochemical associations across CKD stages, comparative designs for predefined patient groups, and cohorts for progression or temporal change. Dialysis studies can also use repeated measurements when the sampling time in relation to dialysis is standardised.

3. What should I settle with my guide before starting the study?

Agree on the CKD definition, staging method, primary biochemical endpoint, eGFR equation, creatinine assay, inclusion or exclusion of dialysis patients, sample timing and major confounders. Also decide whether acute kidney injury, nephrotic-range proteinuria, severe malnutrition, active infection and medications affecting the chosen biomarker will be excluded, stratified or adjusted for in the analysis.

4. Can I use retrospective laboratory data for a renal biochemistry study?

Yes, if the records document chronic kidney disease adequately and contain the variables needed to apply the intended definitions. Retrospective work is weaker when chronicity cannot be established, when eGFR cannot be calculated from reliable creatinine values, or when dialysis timing is unknown. Changes in assay platform during the study period should also be checked before combining results.

5. What is the difference between a renal biochemistry synopsis and a protocol?

The synopsis presents the rationale, objectives, design and broad methodology for academic approval. The protocol contains the operational detail needed to reproduce the study, including CKD diagnostic criteria, eGFR equation, specimen timing, assay methods, dialysis status, exclusion criteria, derived calculations and statistical analysis. In renal research, these details determine whether biochemical differences reflect disease severity or methodological variation.

6. What ethical issues should I address in renal biochemistry studies?

Prospective studies involving children require guardian consent and, from about seven years where appropriate, child assent. Record-based studies may seek a waiver of consent when permitted by the ethics committee and when confidentiality safeguards are adequate. Research-only venepuncture should be minimised and the additional blood volume should be explicitly limited according to age and institutional policy. Extra radiation, contrast exposure or invasive renal procedures are not justified solely for a biochemical endpoint. Separate consent is required for identifiable photographs or video. The protocol should also define a clinical pathway for serious incidental findings such as severe hyperkalaemia, marked metabolic acidosis, critical hypocalcaemia, very high creatinine or other laboratory abnormalities requiring urgent review.

7. Why can serum creatinine and true renal function disagree in CKD research?

Serum creatinine is influenced not only by glomerular filtration but also by muscle mass, age, sex, diet, tubular secretion and assay interference. A patient with low muscle mass may have advanced renal dysfunction despite a relatively modest creatinine concentration, while a muscular individual may have a higher creatinine without equivalent loss of filtration. This is why a renal biochemistry study should not analyse creatinine alone when the research question concerns kidney function; the eGFR equation, assay calibration and patient phenotype should be specified.

8. How is a PhD proposal different from an MD Biochemistry synopsis?

An MD synopsis is usually centred on a focused clinical-biochemical question that can be completed during postgraduate training using available patients and laboratory facilities. A PhD proposal generally requires a broader and more original programme of investigation, often with mechanistic work, longitudinal components or multiple linked objectives. The expected novelty, depth and duration are therefore different.

9. When should I register my renal biochemistry thesis topic?

Registration should follow confirmation that the required CKD population, laboratory assays, staging information and ethics pathway are available. It should be completed early enough to allow protocol approval, recruitment and repeat biochemical testing where needed, particularly when chronicity or serial measurements are important to the research question.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×